Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Microbiota in health and diseases
2022 Standout
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
2020
From NASH to HCC: current concepts and future challenges
2019
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Mechanisms of hepatic stellate cell activation
2017 Standout
Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States
2012
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations
2014
Burden of liver diseases in the world
2018 Standout
Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study
2013
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
2013
Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease
2011
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
2016
The changing epidemiology of liver diseases in the Asia–Pacific region
2018
Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver
2016
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy
2015
Nonalcoholic fatty liver disease in Asia: emerging perspectives
2016
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
2014
Bariatric Surgery Improves Histological Features of Nonalcoholic Fatty Liver Disease and Liver Fibrosis
2014
Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease
2011
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
2012
Non-alcoholic fatty liver disease
2021 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
2013
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
2011
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis
2015
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
2013
Global burden of liver disease: 2023 update
2023 Standout
Radiologic evaluation of nonalcoholic fatty liver disease
2014
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
2016
The global NAFLD epidemic
2013 Standout
NAFLD in Asia—as common and important as in the West
2013
Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis
2018
What We Talk About When We Talk About Fat
2014 Standout
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
2009
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
2017
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology
2015
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
2012
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
2014
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study
2013
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
2014
NAFLD: A multisystem disease
2015 Standout
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
2014
Gut microbiota in human metabolic health and disease
2020 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Association of obstructive sleep apnoea with the presence and severity of non‐alcoholic fatty liver disease. A systematic review and meta‐analysis
2013
Magnesium in Man: Implications for Health and Disease
2014 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Multiple benefits of legumes for agriculture sustainability: an overview
2017 Standout
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study
2020
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease.
2013
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Achievements and Challenges in Improving the Nutritional Quality of Food Legumes
2014
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
2016
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region—the GO ASIA initiative
2018
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
2020
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
2012
Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
2017
Histologically proven non‐alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation
2014
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
NAFLD and Chronic Kidney Disease
2016
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
2015
Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
2013
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
2013
Nonalcoholic Fatty Liver Disease
2015 Standout
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
2013
Natural history of NASH and HCC
2020
Green tea extract provides extensive Nrf2‐independent protection against lipid accumulation and NFκB pro‐ inflammatory responses during nonalcoholic steatohepatitis in mice fed a high‐fat diet
2015
Works of H.-Y. Chan being referenced
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
2010
In vitro interactions on glucose by different fiber materials prepared from mung bean hulls, rice bran and lemon pomace
2020